Gerd - Nursing Case Study

Pathophysiology

• Primary mechanism: Gastroesophageal reflux disease (GERD) primarily results from the dysfunction of the lower esophageal sphincter (LES), which normally acts as a barrier to prevent stomach contents from flowing backwards. In GERD, the LES becomes weak or relaxes inappropriately, allowing acidic gastric contents to reflux into the esophagus, leading to irritation and symptoms like heartburn.

• Secondary mechanism: Delayed gastric emptying can exacerbate GERD by increasing gastric volume and pressure, which promotes reflux. This delay may result from factors like gastroparesis or certain medications, further contributing to the frequency and severity of reflux episodes.

• Key complication: Chronic exposure of the esophageal lining to stomach acid can lead to esophagitis, characterized by inflammation and ulceration. Over time, this may progress to Barrett's esophagus, a condition with a heightened risk of developing esophageal adenocarcinoma.

Patient Profile

Demographics:

45-year-old male, office manager

History:

• Key past medical history: Diagnosed with GERD 3 years ago, occasional smoker, hypertension

• Current medications: Omeprazole 20 mg daily, Lisinopril 10 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent heartburn and difficulty swallowing

• Key symptoms: Regurgitation, chronic cough, hoarseness, chest pain after meals

• Vital signs: Blood pressure 145/90 mmHg, heart rate 88 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F

Section 1

New Diagnostic Results:

During the follow-up visit, the physician orders an esophagogastroduodenoscopy (EGD) to evaluate the esophageal mucosa due to the patient's persistent symptoms, particularly the difficulty swallowing and chest pain after meals. The EGD reveals significant esophagitis with ulcerations and areas of mucosal erosion, confirming the presence of inflammation due to ongoing GERD. Biopsies taken during the procedure indicate the early changes associated with Barrett's esophagus, characterized by intestinal metaplasia. This finding is concerning as it signifies a pre-cancerous condition, necessitating careful monitoring and potential treatment modifications.

In addition to the endoscopic findings, a 24-hour esophageal pH monitoring test is conducted to assess acid exposure levels. The results show prolonged periods of acid reflux, with a significant drop in pH levels indicative of severe acid exposure, especially after meals. These diagnostic results, coupled with the patient's symptoms, suggest that the current management with Omeprazole is insufficient. The healthcare team considers increasing the dosage of the proton pump inhibitor or adding an H2-receptor antagonist to enhance acid suppression. The findings also prompt a referral to a gastroenterologist for further evaluation and to discuss potential interventions, such as endoscopic therapy or surgery, to prevent progression to esophageal adenocarcinoma.

Section 2

Following the concerning diagnostic findings, the healthcare team intensifies their focus on the patient's clinical management to prevent progression of the disease. At the next follow-up appointment, the patient presents with new symptoms: increased fatigue, mild anemia, and unexplained weight loss of about 10 pounds over the past two months. Upon physical examination, the patient appears pale, and vital signs reveal a slight tachycardia with a heart rate of 102 bpm, while blood pressure remains within normal limits at 120/78 mmHg.

Laboratory tests are conducted to further investigate these new symptoms. Complete blood count (CBC) results show a hemoglobin level of 10.5 g/dL, which is lower than the normal range, indicating iron-deficiency anemia. The mean corpuscular volume (MCV) is 75 fL, suggestive of microcytic anemia. These findings raise concerns about potential chronic blood loss, likely due to the ulcerations seen in the esophagus during the EGD. Additionally, a ferritin level is obtained, demonstrating low iron stores, which supports the diagnosis of iron-deficiency anemia secondary to gastrointestinal bleeding.

Given these developments, the healthcare team decides to adjust the treatment plan further. An increase in the Omeprazole dosage is implemented, and an iron supplementation regimen is initiated to address the anemia. The patient is also educated on the importance of dietary modifications to reduce reflux symptoms and minimize further mucosal damage. The gastroenterologist discusses the potential need for endoscopic therapy to manage the Barrett's esophagus and prevent further complications. This comprehensive approach aims to stabilize the patient's condition and prevent progression to more severe outcomes, requiring careful monitoring and follow-up to evaluate the efficacy of the interventions.

Section 3

A few weeks after the adjustment in the treatment plan, the patient returns for a follow-up appointment. During this visit, the patient reports feeling slightly more energetic, but still experiences intermittent fatigue and occasional episodes of dizziness, particularly when standing up quickly. The weight loss has stabilized, but there has been no significant regain of the previously lost weight. Upon examination, the patient still appears pale, and the vital signs reveal a heart rate of 98 bpm with blood pressure at 118/76 mmHg, suggesting some improvement in the tachycardia but persistent signs of anemia.

A repeat complete blood count (CBC) shows a slight improvement in hemoglobin levels, now at 11.2 g/dL, indicating a positive response to iron supplementation. The mean corpuscular volume (MCV) remains low at 76 fL, suggesting ongoing microcytic anemia. Ferritin levels have slightly increased but are still below normal, highlighting the need for continued iron therapy and monitoring. Despite these positive trends, the healthcare team is concerned about the potential for further gastrointestinal bleeding, given the history of esophageal ulcerations.

In light of these findings, the gastroenterologist emphasizes the importance of endoscopic monitoring to assess esophageal healing and evaluate the need for further intervention. The patient is scheduled for a follow-up endoscopy to determine the effectiveness of the current treatment regimen and to check for any new ulcerations or progression of Barrett's esophagus. The patient is counseled on maintaining adherence to dietary changes and medication compliance to support healing and prevent further complications. This approach underscores the need for ongoing vigilance and clinical reasoning to anticipate and address any emerging issues in the patient's management plan.

Section 4

Several weeks after the follow-up appointment, the patient returns for the scheduled endoscopy. The procedure reveals partial healing of the esophageal ulcers, with some areas showing significant improvement while others remain inflamed. Notably, there are new findings of small gastric erosions, raising concerns about ongoing irritation from gastric acid despite the current proton pump inhibitor (PPI) regimen. The Barrett's esophagus appears stable with no signs of dysplasia, which is reassuring, but the presence of new gastric erosions prompts the healthcare team to reconsider the patient's current management strategy.

In response to these findings, the gastroenterologist recommends increasing the PPI dosage to provide more effective acid suppression, in conjunction with adding a histamine-2 receptor antagonist (H2RA) at bedtime to extend acid control throughout the night. The patient is educated on the importance of avoiding non-steroidal anti-inflammatory drugs (NSAIDs) and other gastrointestinal irritants, as well as continuing to adhere to dietary modifications. Furthermore, the team discusses the potential need for a laparoscopic fundoplication if medical management fails to prevent further complications.

The clinical team remains vigilant, recognizing the patient's complex presentation and potential for further complications. They schedule regular monitoring of the patient's hemoglobin and ferritin levels to ensure continued improvement in the anemia and to detect any signs of covert bleeding. The patient is encouraged to report any new symptoms promptly, such as increased abdominal pain or changes in stool color, which could indicate further gastrointestinal issues. This proactive approach aims to maintain the patient's stability, prevent progression to more severe complications, and ultimately improve quality of life.

Section 5

Two weeks after the adjustment in medical management, the patient returns to the clinic for a follow-up evaluation, presenting with new symptoms of increased fatigue and mild dizziness. During the initial assessment, the nurse notes that the patient appears pale and slightly diaphoretic. Vital signs reveal a blood pressure of 100/60 mmHg, heart rate of 92 beats per minute, and respiratory rate of 18 breaths per minute. The patient denies any significant abdominal pain but reports intermittent nausea and a change in stool color, describing it as darker than usual. This raises immediate concern for potential gastrointestinal bleeding.

The clinical team promptly orders a complete blood count and a fecal occult blood test. Laboratory results indicate a hemoglobin level of 10.5 g/dL, down from the previous 11.8 g/dL, and a ferritin level that has decreased to 15 ng/mL, suggesting worsening anemia. The fecal occult blood test returns positive, confirming gastrointestinal blood loss. These findings, combined with the new gastric erosions observed during the recent endoscopy, suggest that the patient may be experiencing ongoing bleeding, potentially exacerbated by the gastric erosions and underlying esophagitis.

In response to these developments, the healthcare team considers the necessity of a more aggressive intervention. They discuss the potential benefits of a laparoscopic fundoplication to address the underlying gastroesophageal reflux that may be contributing to the erosions and bleeding. In the interim, the team intensifies the patient's medical regimen by optimizing acid suppression therapy and ensuring strict adherence to dietary and lifestyle modifications. They emphasize the critical importance of avoiding any medications or substances that could further irritate the gastrointestinal tract. The patient is scheduled for more frequent follow-up appointments to closely monitor the response to these interventions and to prevent further deterioration of the condition.